Tomislav Dragovich is an Oncology physician affiliated with Baptist Cancer Center. OpenAlex indexes 131 publications with 4,491 citations (h-index 29); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1301 Palm Ave Ste 700
Jacksonville, FL 322078457
Telephone
904-202-7300Provider last certified this registry record 30 Apr 2025.
Clinical trials
- Project Survival-Prospective Biomarker Discovery
Sponsor: Pancreatic Cancer Research Team
- PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
Sponsor: Pancreatic Cancer Research Team
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Intera Oncology, IncProgram year20251 payment
- Novocure Inc.Program year20251 payment
- Lilly USA, LLCProgram year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
50.8%Serotonin-3 Receptor Antagonist28%Ondansetron Hcl100%Part D≥27 patientsAntidiarrheal microorganisms13.6%Creon100%Part D<11 patients+ 1 more class in this area
Nervous system
31.1%Phenothiazine31.1%Prochlorperazine Maleate100%Part D≥26 patientsCardiovascular
9.8%Antiarrhythmic9.8%Lidocaine-Prilocaine100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Nature Reviews Clinical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”